BOSTON, Jan. 03, 2024 Atea Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases,.
Atea Pharmaceuticals Announces Participation at Upcoming Investor Conferences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
This past week, IPWatchdog was made aware of a petition for post-grant review (PGR) proceedings at the Patent Trial and Appeal Board (PTAB) that raises interesting arguments about allegedly inconsistent statements on patentability made during legal proceedings by pharmaceutical firm, Gilead Sciences.
NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) and Atea Pharmaceuticals (NASDAQ:AVIR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, dividends, analyst recommendations and risk. Institutional & Insider Ownership 71.3% of Atea […]
CalciMedica (NASDAQ:CALC – Get Rating) and Atea Pharmaceuticals (NASDAQ:AVIR – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Insider and Institutional Ownership 71.3% of Atea Pharmaceuticals shares are […]